BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 6 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,000 | – | 1,191 | +1253.4% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 88 | -12.0% | 0.00% | – |
| Q1 2017 | $1,000 | -50.0% | 100 | -79.4% | 0.00% | – |
| Q3 2016 | $2,000 | -33.3% | 486 | -38.7% | 0.00% | – |
| Q1 2016 | $3,000 | – | 793 | +3865.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 20 | -98.4% | 0.00% | -100.0% |
| Q2 2015 | $6,000 | – | 1,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRUE Private Wealth Advisors | 55,500 | $64,000 | 0.01% |
| Aspire Private Capital, LLC | 1,600 | $2,000 | 0.00% |
| ROYAL BANK OF CANADA | 2,540 | $3,000 | 0.00% |
| UBS Group AG | 4,692 | $5,000 | 0.00% |
| CREDIT AGRICOLE S A | 4,240 | $5,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 200 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 13,768 | $16,000 | 0.00% |
| MORGAN STANLEY | 33,281 | $39,000 | 0.00% |
| Renaissance Technologies | 18,300 | $21,000 | 0.00% |